Fundz

Byheart Acquires Additional Domestic Infant Formula Manufacturing Facility Tripling Its Supply Capacity And Continuing To Fortify Formula Production In The U.S.

PRIVATEJan 25, 2023

Acquiring Company

ByHeart

Acquired Company

Infant Formula Manufacturing Facility

New YorkManufacturingHealthcareHealth Care

Description

Today, ByHeart announces the acquisition of an additional manufacturing facility that will enable the next-generation baby nutrition company to scale production capacity of its breakthrough infant formula and increase domestic infant formula supply. Recognizing that the formula industry, which historically has been dominated by three players who control 90% of the market, was in need of change, ByHeart founders Ron Belldegrun and Mia Funt began working with DairiConcepts' FDA-registered facility in Allerton, Iowa, in 2018 to proactively build redundancy into their production ecosystem.

Who to call at ByHeart, and when

When ByHeart changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day ByHeart raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ByHeart, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ByHeart

Location

131 Varick Street

New York, New York, United States

About

ByHeart is an infant nutrition company built from the ground up to deliver real innovation on behalf of babies and parents. Our mission is simple: make the best formula in the world. That’s why we studied the latest breast milk science, worked directly with suppliers we know and trust, set uncompromising quality standards, developed our own small batch blending process, built our own manufacturing facilities, and conducted a groundbreaking clinical trial. Our goal is to create a future where all parents feel amazing about feeding their baby—no matter how they do it.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ByHeart makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mia
Senior decision-maker at this company
••••••••@••••••••

See Mia's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ByHeart's next move

Learn about Strategic plan

Frequently asked

Who acquired Infant Formula Manufacturing Facility?

Infant Formula Manufacturing Facility was acquired by ByHeart, based in New York. The deal was reported on January 25, 2023. ByHeart is an infant nutrition company built from the ground up to deliver real innovation on behalf of babies and parents. Our mission is simple: make the best formula in the world. ByHeart is privately held and operates in Manufacturing.

When did ByHeart acquire Infant Formula Manufacturing Facility?

ByHeart's acquisition of Infant Formula Manufacturing Facility was reported on January 25, 2023. Today, ByHeart announces the acquisition of an additional manufacturing facility that will enable the next-generation baby nutrition company to scale production capacity of its breakthrough infant formula and increase domestic infant formula supply. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Infant Formula Manufacturing Facility do?

Infant Formula Manufacturing Facility is the company acquired in this transaction. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.